Gerassimos M. Makrigiorgos, Ph.D.
This page shows the publications co-authored by Gerassimos Makrigiorgos and Srinivas Sridhar.
Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond). 2014 May; 9(7):1063-82.
Third generation gold nanoplatform optimized for radiation therapy. Transl Cancer Res. 2013 Aug; 2(4).
DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiat Res. 2012 Dec; 178(6):604-8.
Radiosensitizer-eluting nanocoatings on gold fiducials for biological in-situ image-guided radio therapy (BIS-IGRT). Phys Med Biol. 2010 Oct 21; 55(20):6039-52.
Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release. Pharm Res. 2010 Aug; 27(8):1738-45.
Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):615-23.
Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption. PLoS One. 2020; 15(7):e0236245.
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy. Nano Lett. 2015 Nov 11; 15(11):7488-96.
Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):385-92.
In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine. 2013 Jan; 9(1):25-7.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.